Uveitis Trial, Recruiting NCT05904301 Sponsor: Santé Arménie French-Armenian Research Center Condition: Uveitis
Back to Uveitis

Uveitis Trial, Recruiting

NCT05904301
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with at least one of the following conditions: Behçet's disease, ANCA-positive vasculitis, Takayasu arteritis, Giant cell arteritis, Systemic sclerosis, Sjögren's syndrome, Rheumatoid arthritis, Spondylarthritis (including psoriatic, ankylosing, or Crohn's-related), Hereditary or acquired angioedema, Pediatric skin conditions, Autoinflammatory diseases (hereditary or acquired), Unexplained infertility, Immune thrombocytopenic purpura or Autoimmune hemolytic anemia, Primary anti-phospholipid syndrome, or Coeliac disease
  • You can be any age — both adults and children are eligible
  • You (or your legal guardian, if applicable) have been given information about the trial and have agreed to take part in writing

Who may not be able to join:

  • You do not wish to take part in the registry
  • If you are a child or cannot consent for yourself, your legal guardian or representative has not agreed to give consent on your behalf
  • You are currently pregnant or breastfeeding

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Merry Mazmanian, Dr., Santé Arménie French - Armenian Academic Research Organization FAARO

Phone: 01 49 28 23 92

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Santé Arménie French-Armenian Research Center
Registry
ClinicalTrials.gov
Start date
21 June 2023
Est. completion
30 June 2028

Where this trial is recruiting

Armenia

Primary endpoints

Systemic manifestations and evolution of the diseases under treatment by disease-specific activity scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov